POZ - Latino Hub : News : Utah Researchers Make Progress on “Molecular Condom”

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » News


 

February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

August 12, 2009

Utah Researchers Make Progress on “Molecular Condom”

Scientists at the University of Utah in Salt Lake City are developing a unique vaginal gel, dubbed a “molecular condom,” which could be tested on humans in the next few years, the Deseret News reports.

According to the article, the substance is inserted into the vagina before sex and turns solid in the presence of semen, protecting vaginal tissue by trapping HIV particles in a microscopic mesh.

“We did it to develop technologies that can enable women to protect themselves against HIV without approval of their partner,” said bioengineering professor Patrick Kiser, PhD. “This is important—particularly in resource-poor areas of the world like sub-Sahara Africa and south Asia, where, in some age groups, as many as 60 percent of women already are infected with HIV. In these places, women often are not empowered to force their partners to wear a condom.”

Older versions of the contraceptive were inserted as a liquid, turned to a gel to coat the vaginal cavity and turned liquid again in the presence of semen to release an anti-HIV drug. This method was ineffective, either because the drugs were not strong enough or did not last long enough or because patients did not use them correctly. High temperatures in Africa also prevented the gel from liquefying and adequately coating the vagina.

Kiser adds that while the product is being researched for developing countries, the U.S. Food and Drug Administration must approve it, and it is likely that a pharmaceutical company will market the drug in the United States as well.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Lora Alstrom, pasadena,ca., 2009-08-13 16:02:10
the lack of funding for edjucation i feel would play a key role in the use of this method. it could very well backfire.Poz. women may think they cant spread there HIV with non HIV Partners by using this gel. Who is going to edjucate all these people and where are the funds going to come from to edjucate this method.

Joao Marinho, Brazil, 2009-08-13 15:15:04
Why are there so many researches about avoiding HIV transmission between straight couples, and I don't see the same number about gay ones? The organizations say that gays have higher risk to HIV. I think we must have more research about this via of transmission...

comments 1 - 2 (of 2 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.